TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: WOMAC overall score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean apical leakage value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary excretion of furosemide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-Free Survival at 4 months (PFS-4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-related treatment-emergent adverse events of grade ≥3
Endpoint domain: Adverse events/effects
Primary endpoint: low birth weight incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: phase coherence in the myogenic frequency interval III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of thromboembolism (TE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Induction failure associated with induction TE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dissociated movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent-reported functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Disability reduction (modified Rankin Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate at six-month follow-up
Endpoint domain: Mortality/survival
Primary endpoint: Change in BNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Aneurysm rupture risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in alcohol consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of peer education on PMS management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of ventricular arrhythmias
Endpoint domain: Adverse events/effects
Primary endpoint: SAA reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Probability of achieving normal CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Upstaged CT severity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: waiting time for kidney transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microarray antibody responses to virion membrane proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Correlations with PRNT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Early clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to eGFR reduction of 50% or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: time to end-stage renal disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: time to renal or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Number of hyperglycemic episodes on Day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Achieving BP <140/90 mm Hg at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oral Mucositis Weekly Questionnaire-Head and Neck Cancer score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary incontinence development
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in Global Health Status
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in Role functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Duration of nystagmus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement of LIDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-reported life-quality assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Achieved steady worker status
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Worked significantly more weeks
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Earned significantly more income
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 50 m swim time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥4-point reduction in DLQI at Week 16
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in affected body surface area (BSA) at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in PASI at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: headache pain-free at 2 hours postdose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived room for involvement in decision making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative nerve injury rate
Endpoint domain: Adverse events/effects
Primary endpoint: school day counts per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: implant angular deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Matsuda insulin sensitivity index (ISI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: subjective insomnia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: objective sleep latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: augmentation in mydriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for ureteric dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-operative fever
Endpoint domain: Adverse events/effects
Primary endpoint: Intra-operative vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean T1 increase in HPV blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean T2* increase after ingestion of oxygenated water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: well-being measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hospitalization rate due to biopsy related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Annualized relapse rate (ARR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Serum levels of RANKL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of TNFRSF9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of bone turnover markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with any local adverse reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of swelling at vaccination site
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal diameter of erythema
Endpoint domain: Adverse events/effects
Primary endpoint: double-support time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum Drug Liking (DL) Emax
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean preoperative aggregated KOOS4 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: local dynamic stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MTC variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stride length variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful liberation from RRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response-time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in NRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rate (≥ 2 points reduction on NRS pain score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness for VTE prophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of developing a multilingual web-based training program
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: ECOG scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical fitness measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in fibrosis stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net fibrosis progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse wave velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Decrease in spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Increase in amplitude of voluntary movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: BASDAI overall spinal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BASDAI fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: WPAI overall work impairment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: new-onset psychiatric disorder
Endpoint domain: Adverse events/effects
Primary endpoint: PaO2 at 5 min after pre-oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time-to-event
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: soft tissue improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PES score after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: linearity of tissue quantitative values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tissue segmentation quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital cost per day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of LNs harvested
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reporting of baseline characteristics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Over-representation of very small p-values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evidence of non-random sampling
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: levels of empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: caring efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: levels of burnout
Endpoint domain: Adverse events/effects
Primary endpoint: ID-TLR
Endpoint domain: Mortality/survival
Primary endpoint: Thickness measurement reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cross-sectional area measurement reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length measurement reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anticipated liking of a novel fruit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: consumption of a novel fruit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with weight loss counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: maximum flexion angle of the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Forgotten Joint Score (FJS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival (PFS2)
Endpoint domain: Mortality/survival
Primary endpoint: enhancing patient-centered care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to first HIV care visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of HIV outpatient care visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain-derived neurotrophic factor (BDNF) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: neurotrophin (NT)-3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of at least grade 2 hand-foot syndrome (HFS)
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of major adverse cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of stroke or systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Creatine Kinase (CK) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: shortened time to maximal adoption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: increased maximal adoption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: preventative cardiovascular care in HIV clinics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence to blinded study medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in S. mutans population
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gtfB gene expression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of stunting, wasting, and underweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in hand-flapping stereotypic behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in body-rocking stereotypic behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continence rate 3 months after surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mMASI score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoglycaemia event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of intradialytic hypotension (IDH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic Blood Pressure (SBP) decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diastolic Blood Pressure (DBP) decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HLA-DRB1*08:01 allele presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: G6PDH deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of influenza vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of death or tracheostomy/PAV
Endpoint domain: Mortality/survival
Primary endpoint: First hospitalisation
Endpoint domain: Mortality/survival
Primary endpoint: Symptom prevalence and severity (SPW)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in Visual Acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infections requiring a prescription
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of predischarge pulmonary congestion (PC) assessed by ΔLIR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overweight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inadequate fruit/vegetable intake reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: mean active range of motion during extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean active range of motion during right rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean active range of motion during lateral flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGF-1 increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fat-free mass index (FFMI) increments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Invasive disease-free survival events
Endpoint domain: Mortality/survival
Primary endpoint: pVAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: yeast counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: CADESI‐04 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: median disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infection rates in epidural puncture sites
Endpoint domain: Adverse events/effects
Primary endpoint: annualized growth velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of thrombophlebitis
Endpoint domain: Adverse events/effects
Primary endpoint: Time required for catheter insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in NSS after probiotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the intake of pharmacological therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Dynamic mechanical allodynia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanical temporal summation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion with vaccine seroresponse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: miRNA-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mindfulness level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: performance in repeated sprint tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of screen-detected cancer
Endpoint domain: Mortality/survival
Primary endpoint: Rate of adverse responses
Endpoint domain: Adverse events/effects
Primary endpoint: symptomatic Covid‐19
Endpoint domain: Adverse events/effects
Primary endpoint: severe disease
Endpoint domain: Adverse events/effects
Primary endpoint: death from Covid‐19
Endpoint domain: Mortality/survival
Primary endpoint: Gait speed per the 10-m Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-linear walking assessment per the Figure-of-8 Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic balance assessment per the 360 Degree Turn Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary tract infections (UTIs) not requiring hospitalisation
Endpoint domain: Adverse events/effects
Primary endpoint: Stoma self-care independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete neurological recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transition to accurate PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in accurate PA state (State 4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IOP difference postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HC radius of curvature change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deformation amplitude change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for analgesics postoperatively
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with appropriate transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average time to fix the block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average duration of action
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable perceptions of cigarillos
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status